The Nittany Turkey

Primarily about Penn State football, this is a tale told by idiots, full of sound and fury, signifying nothing.

Search This Site

Enter keyword(s) below to search for relevant articles.

  • Penn State Football
  • Mounjaro Update Catalog
  • Contact Us
  • About Us
Home Archives for Health

Mounjaro Weekly Rant: Big Pharma, Little Pharma, No Pharma

Posted on September 30, 2024 Written by The Nittany Turkey 1 Comment

Mounjaro

This is my weekly Mounjaro update, which chronicles my progress with the current vogue GLP-1/GIP-1 drug. Writing is therapeutic for me, and if it provides a modicum of useful information to my readers, I’m happy.

First, I want to comment on a hot topic. An Internet rumor is circulating about the possible end of compounded tirzepatide, the generic version of Mounjaro and Zepbound. After I blow enough wind about that rumor and its implications, I’ll get to my numbers. This will be a shorter overall rant than last week’s because we both deserve a break.

In Reddit We Trust

The hot, rapidly spreading Reddit rumor is that the USFDA is preparing to remove Mounjaro and Zepbound from the shortage list in October. This is causing great distress among those who rely on compounding pharmacies for a cheaper alternative than the branded drugs. The basis for the rumor is an FDA response to a citizen’s query, in which that regulatory organization unwittingly dropped a hint about the shortage’s end. The upshot is that if the FDA says, “no shortage”, compounding pharmacies will not be permitted to sell tirzepatide.

No doubt, Eli Lilly & Company, the manufacturer of Mounjaro and Zepbound (both of which are brand names for tirzepatide), will push the FDA to move their case along. Of course, aggrieved parties, namely, the compounding pharmacies, will file lawsuits. Likely, Eli Lilly, a huge multinational corporation with deep pockets and massive lobbying influence, will prevail. Once the ball starts rolling, it is just a matter of time before the compounders are unable to sell tirzepatide. The headline will read, “Big Pharma to Little Pharma: Drop Dead!“

Compound Fractures

Two types of compounders, designated by their legal classification 503a and 503b, are affected. Right now, both sell uncompounded, generic tirzepatide, but after the drug comes off the shortage list, neither can legally do that.

In the case of 503a pharmacies, the good old-fashioned compounders, they still can accept legitimate prescriptions for compounded tirzepatide. Here, compounding means that the drug is mixed with Vitamin B12, for example, due to prescribed requirements for specific patients. However, they will need to stop selling uncompounded tirzepatide immediately.

A Hard Pill to Swallow

The 503b pharmacies, the ones that sell plain old tirzepatide, are typically mail-order pill mills. Some of them sprang up to sell boner pills after Pfizer created a market for them after the seminal introduction of Viagra (pun intended) and the fun drug subsequently went off patent. The FDA will allow a grace period during which 503b pharmacies can fulfill existing orders. I’m hearing that this can be for up to sixty days.

Presently, we are dealing with more speculation than fact. However, the shortage resolution will happen eventually if not in October, at which time the FDA will impose the restrictions. Certainly, Eli Lilly will push to hasten that outcome. It is their drug, they brought it to market at considerable expense for R&D, patentng, advertising, and production, so they want to protect what is theirs.

The parasitic compounders will suffer, as will those who opted to take the risk of using them. Ignorance of the enabling situation, namely, the necessarily temporary shortages of Mounjaro, Zepbound, Ozempic, and Wegovy, exacerbated by the marketing efforts of the compounders and their telehealth partners, lulled these patients into a false sense of security. What to do when the compounding channel goes away?

Will Widespread Panic Prevail?

I suspect that tirzepatide addicts using the compounded products will panic due to Internet-fed rumors about the supply shutdown. Some will exhort their doctors to prescribe compounded versions for which they might not have a specific need. However, Lilly has been getting nosy about such contrived scripts and I could see them using the courts to pressure doctors with the threat of losing their licenses.

Other tirzepatide junkies might order huge quantities of the precious drug. Either they will feed their own habits or, when the dawn of profitability realization breaks on their thick skulls, they might enter the resale market, which, of course, is illegal as hell.

Any way you slice it, there will be chaos in the tirzepatide market!

The Danger of Questionable Sources

Another big issue with people buying large quantities of these drugs from questionable suppliers is their unknown shelf-life. What is the danger of things going wrong as they age? Many are reconstituted, and who knows what the labs are using as preservatives?

Unlike with Lilly, the FDA does not exert tight quality control over these compounded products. From some compounding pharmacies, tirzepatide might be perfectly safe, but from others, patients might be taking their life in their hands, injecting tainted substances into their bodies. Remember the case of New England Compounding Pharmacy and the one hundred deaths associated with one of their injectable compounded products? The principals were jailed ex post facto, but too little, too late. People died.

How About Third-World Tirzepatide?

Another possibility is that desperate weight-loss addicts will seek out foreign sources for their substances. I saw an Australian Broadcasting Company programme about a compounding pill mill Down Under that was illegally selling semaglutide (sister drug to tirzepatide) into the U.S. They interviewed some of the Americans who were bilked by the pill mill. They told horror stories about the unusable products they received.

So, I can foresee all kinds of problems arising in the future stemming from people’s outsize desire to lose weight. They’ll flail around blaming Eli Lilly for being greedy, but they’ll either be dealing with Lilly’s prices or with their black-market suppliers.

While the long-term outlook for the pill mills might be uncertain, I bet they will experience a significant bump in sales in the short term. Addicts will be addicts, and addicts must get their fix.

The big question in my mind is: How stupid will desperate people be regarding where and how they get their drugs?

My Progress on Mounjaro

Now, let’s move on to my progress on Mounjaro.

My glucose average for the week, as reported by my Dexcom Stelo, was 107 mg/dL. This is an improvement, and it equates to an A1c of 5.4. We’re homing in on my target of 5.2! My weight increased 1.6 pounds since last Monday, which is no cause for concern in the aftermath of my rapid, COVID-influenced weight loss (ten pounds in a week).

Blood pressure has been an issue since the COVID episode. Back on the 100 mg dose of Losartan, my average was 135/80. Before my vacation, I had been averaging 119/70 after reducing the Losartan to 50 mg. I believe my blood pressure will improve when I can resume a decent exercise regimen, which I suspended due to COVID and back/hip issues. Along those lines, before I close this week’s all-about-me Mounjaro progress journal, I’ll take a side-trip to da hip.

Back and Hip Issues, You Say?

During my vacation, I tweaked my back, and wound up with sciatica-like symptoms, which continue now, close to a month later. My doctor, who opts for conservative treatments first, told me to try Alleve for two weeks. I did, and it didn’t help. I still have thigh pain and numbness. So, I have put in a request for him to order an MRI so we can see what is going on in there. Without the diagnostic imagery, I am flying blind. I have no idea whether I am dealing with a disc issue, a nerve issue, or a hip degeneration issue. I had my left hip replaced in 2001; now, could the right hip be shot, too?

With hopes of confirming that or eliminating it as a possibility, I attempted to make an appointment with Dr. Kahuna, my knee guy, who is also a hip replacement surgeon. In fact, he trained under the surgeon who replaced my left hip. However, without imaging to support the notion that a hip replacement might be necessary, the policy of the orthopedic clinic is to use a physician extender to evaluate the condition before bothering the big kahuna with a case that might not require his expert surgical intervention. So, I made an appointment with an unknown physician assistant named Laura.

Aesthetically Speaking

I did some background checking on Laura. Turns out that she either runs or ran an “aesthetic” clinic. You know what that is? Botox and lip inflation for rich matrons. Her reviews for that clinic were terrific, but what in the bloody hell does vaginal reconstruction have to do with evaluating my hip? This revelation further underscored the need for me to get the damn MRI. While I originally thought it might be fun to have the conversation with Laura to get her story, who the hell has the time for such entertainment?

If the MRI says I need a hip replacement, I can skip the extender evaluation and go straight to Dr. Kahuna. Once I receive the order from Dr. DeLorean, I’ll cancel the vaginal rejuvenation evaluation. If the MRI results point elsewhere, I’ll deal with that. Flying blind sucks!

Wrapping It Up and Putting a Bow on It.

That’s it for this week. In the coming weeks, we’ll no doubt learn more about the travails of the Little Pharma vs. Big Pharma. And I hope to be back next week with some new tidbits associated with my Mounjaro therapy and my general state of being.

Until then…

Share this:

  • Click to email a link to a friend (Opens in new window) Email
  • Post
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to print (Opens in new window) Print
  • More
  • Pocket
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...

Filed Under: Health, Mounjaro Tagged With: compounding pharmacies, hip replacement, tirzepatide

Mounjaro Update: Covid, Stelo, and My Story

Posted on September 23, 2024 Written by The Nittany Turkey Leave a Comment

Mounjaro

Welcome to another weekly Mounjaro update, where I describe my personal progress on the drug and blow wind about related issues.

Yesterday morning’s COVID test was negative! So, I’m hoping to conclude that episode. From the time I tested positive on Wednesday until now it is a little more than the expected ten days. Although I still feel fatigued and crusty, I hope to bounce back soon. Being an old fart, recovery time is always longer. However, I spent half an hour on the stationary bike yesterday to test my exercise tolerance with no issues.

Another situation that arose over the vacation was lower back pain and sciatica, which still afflict me. The doc threw some Alleve at it, but it isn’t working. As the back pain causes loss of sleep, I assume that it is contributing to my high blood pressure, which despite weight loss, has been unacceptably high since my return.

This week’s issue will provide additional information about the new, non-prescription, wearable glucose monitors. I am using Stelo by Dexcom, and during the week I discovered that Abbott Labs has a competing product. After that, I provide a soul-searching narrative about my latest irresponsible, self-deluding weight gain, which made me even sicker, precipitating my Mounjaro therapy. Of course, I need to toss in an editorial about how obesity is not a disease for which the only reasonable treatment is with pharmaceuticals. Finally, I will provide an update of my progress on Mounjaro.

It’ll be a long one, but it’s free! You can’t beat that with a stick!

Stelo Update

Last week, I talked about the Stelo biosensor, a continuous glucose monitor-like product from Dexcom that is available over the counter directly from the manufacturer. I couldn’t believe that Dexcom’s major competitor in the diabetes market, Abbott Labs, would allow Dexcom to scoop that market segment. They haven’t, as they are marketing a competitively priced product of similar capabilities, called Lingo. I have not yet explored its capabilities, as I am satisfied with the Stelo, but I have provided links if you wish to make your own comparison. One major issue for me is that Abbott in its dubious wisdom has created an app for the iPhone, but not for Android, which is the platform I use. (Besides, Abbott markets their product as a Lingo “journey” — and you know how I feel about characterizing things as “journeys”.)

Medicare does not cover the cost of continuous glucose monitors for type two diabetics unless they are on insulin or have suffered hypoglycemic episodes. Other insurance companies might have different policies. Furthermore, those covered CGMs require a prescription. The non-prescription Stelo and Lingo devices open fresh territory not only for diabetics, but also for people interested in their metabolic health with no pathology. Everybody can benefit from them for under $100 per month.

Better Than I Thought!

In my prior report, I mentioned that data could not be exported from my Stelo, and the blood glucose history was deficient. That was before I discovered the “Clarity” app from Dexcom, which provides robust reporting and the capability to export a CSV file — exactly what I wanted! Data is stored in the cloud, but I don’t know for how long it is kept.

I have tracked the Stelo against my Contour glucometer. I find that the Stelo reads high by 8-10 mg/dL. However, what I am interested in with the Stelo is gauging the relative effects of what I ingest on my blood sugar. How rapidly the glucose rises and falls is more significant than the absolute values, along with staying in a tight overall range.

One thought on the disparity in readings concerns timing. Because the glucometer measures glucose in the blood, whereas the Stelo measures glucose in the serous fluid, glucose might take more or less time to get to one or the other. Over time, the two methods might well be in closer agreement.

Had I started wearing the Stelo or a similar glucose monitoring device two years ago, I could have avoided the gruesome story you’ll read below.

My Yo-Yo Weight Story, Chapter XXXVIII

I’ve ridden the diet roller coaster for an entire lifetime, almost eight decades. Recently, in 2020, I lost about seventy pounds, and like most chronic yo-yo dieters, I vowed to never pork up again. What made me think I would not break that ridiculous self-promise yet again?

Many of you personally identify with this yo-yo syndrome. In my case, I think I can identify the “why”, but that doesn’t mean it won’t ever happen again with a completely different “why”. The overarching cause is nervous eating, sneaking in carbs, etc., which I cover up with self-delusion. Comfort food does not provide comfort. It causes inflammation and pain. I characterize it instead as an oral fixation, at least in my case.

Between September 2020 and January 2024, I gained forty-eight pounds. The accelerated part of that curve was a thirty-pound pork-up between August 2022 and January 2024. Not coincidentally, in August 2022, I had a bout with diverticulitis and gastritis. After getting those awful ailments under control, my GI doc, who I’ll call Dr. Scrooge, exhorted me to increase my fiber intake. Mind you, I’m not blaming Scrooge here, for it was my implementation of his fiber mandate that was faulty. Instead of healthy vegetables, I took the easy, ultra processed cereal route, as you will see below.

Because of the gastritis, I gave up all forms of alcohol, an abstinence I have maintained straight through. However, I undoubtedly compensated by replacing one ingested form of comfort with another.

Getting My Fiber

My approach to the fiber mandate was shoveling mounds of ultra processed, high-fiber breakfast cereal down my gullet. I discovered that General Mills Fiber One Original is artificially sweetened, so I thought it was a promising idea. Couldn’t hurt, right? (After a while, I came to despise the cloying sucralose sweetening, but hell, I was getting my fiber, wasn’t I?). Whereas a two-thirds cup serving of Fiber One Original provides eighteen grams of fiber, it also nails you with thirty-three grams of carbohydrates. But two-thirds of a cup doesn’t fill a bowl, and more cereal means more fiber, right? Thus, it couldn’t hurt to eat a few bowls per day — more fiber! Yeah, and more carbs, too.

All this with the foreknowledge that I’m a carb-sensitive diabetic. I was oblivious to the danger, because it felt momentarily good to eat the Fiber One crap, which my wife described as “gerbil food.”

Hiding from the Glucometer

I hid from the glucometer and the scale, but A1c tests told me that my average serum glucose was 170 or 180 mg/dL. My blood pressure was elevated, my diabetic neuropathy was keeping me awake at night, and I was miserable. All that misery only made me want more comfort “fiber”.

Look at the ingredients in the “very healthful” Fiber One Original: Whole Grain Wheat, Corn Bran, Modified Wheat Starch, Color Added, Guar Gum, Cellulose Gum, Salt, Baking Soda, Sucralose. 

Cheerios

When General Mills shut down its Fiber One production lines to upgrade them last summer, a shortage ensued. I couldn’t find Fiber One on the shelves anywhere! So, I replaced Fiber One with Cheerios — the original yellow box, not the honey-nut kind. Then, the power of sugar/carb addiction really took hold vigorously. And as I mentioned, I sometimes had two or three bowls per day of the wonderful, inflammation causing grain products, with their sneaky doses of sodium, sugar, preservatives, and guar gum, whatever the hell THAT is! It was easy, load up a bowl, add milk, and bingo! Oral gratification in a box! (Cheerios have no guar gum, but they do add tripotassium phosphate to preserve freshness).

Hyperbolic Pork-Up

The result was that hyperbolic pork-up I mentioned, which I rationalized to my primary care doc, Dr. DeLorean (not his real name), by stating that I was getting my fiber. Dr. Scrooge, my GI doc, who acts like ol’ Ebenezer, but Scrooge is not his real name, either, exhorted me to increase my fiber intake. Yeah, I was rationalizing, kidding myself, but I was not kidding Dr. DeLorean. He upped my blood pressure meds, adding hydrochlorothiazide, and told me that he and I both knew that I could get the diabetes and weight back under control because I had done so before. He knew that I knew that the carbs were the key. Yes, I knew better. But no, I didn’t act better.

Alas, I didn’t heed Dr. DeLorean’s advice. I had been worrying about some incidentally discovered GI issues, which Dr. Scrooge diagnosed in January this year. After fretting over them for a while, shoving down increasingly more comfort food, I found myself entering a destructive thought pattern — hell, if that many things that could kill me, who cares about the diabetes and the weight? Might as well go down stuffing my face and my lifelong obsession with crap food!

Thanks! I needed that!

Fortunately, my pity party did not last. I convinced myself that my self-destructive approach was leading me down into Dante’s inferno, but I was not yet ready to abandon hope. With a crappy lab report in hand, and weight at an uncomfortable peak, I performed a difficult contortionist’s act of putting a foot up my own ass, impelling me to action. And so it was that at the ensuing follow-up visit, Dr. DeLorean and I agreed on Mounjaro for my type 2 diabetes.

This was a serious commitment, as I do not like to throw drugs at health issues that I could treat with self-control and hard work. How many chronic conditions can we treat that way, without resorting to injecting foreign substances into our bodies? This is a silly spiral we’re in, justifying drugs to treat our self-imposed health issues. Yet, there I was, going down the road I and “South Park” had ridiculed.

Obesity is Not a Disease (No Matter What Big Pharma Says)

And that’s my story. I do not feel as if obesity is a disease that requires expensive drugs, although those drugs can be helpful for those who need a crutch. I do feel that the food industry in this country is ridiculously out of control, pandering nutritionally vacuous, ultra processed bags of addictive, health-destroying substances and pushing them onto our plates. Breakfast cereal is a particular scourge. Marketing aimed at our kids, replete with brightly colored cartoon character pimps, hooks them early. The fattening of America is a real thing, caused by the food industry with complicity by the government and the encouragement of Big Pharma. Addict yourself to crap, pork up, and we’ll cure your “disease.”

A Voice of Reason

Dr. Suneel Dhand, one of the rational health commentators on YouTube, recently posited that if doctors in the 1970s had the same “Mr. Fix-It”, procedural attitude as doctors today, instead of telling people to quit smoking, they would have told them to continue, but here’s a once-a-week injection that will fix it for you. Precisely. Conquering smoking addiction was difficult for many people, but those of us (myself included) who knew what was best for us bit the bullet and quit.

Fifty years later, our screwed-up society, which puts personal responsibility at the bottom of the list of priorities and externalized excuses at the top, says we’re so sorry you are “volumetrically challenged” (or some such euphemism), because it is not your fault. But through the miracle of modern pharmacotechnology, we can fix you up! We can develop and subsidize a drug that will help you, you poor, helpless soul!

Victims?

We must not stigmatize fat people, because they are victims, they say. We must treat their unfortunate disease, they say — with high-profit-margin drugs, of course. Denial of responsibility and quick fixes are the American Way in the Twenty-First Century. And if you’re calling it “bullshit”, you’re absolutely right!

Those self-interested advocates promoting obesity as a disease typically cherry-pick studies without following the funding or seeking contrary information. One such YouTube advocate cited “recent” research that poor diet causes insulin resistance which causes basal metabolism to decrease, so therefore, obesity is a disease? Huh? Medical science has long known that yo-yo dieting has that effect. A very few people have a genetic issue that causes obesity, but for most of us, we just eat too much toxic, ultra processed food. Victims? Yes, victims of problems we create for ourselves, although our toxic food environment severely constrains our choices.

Another Specious Argument

Another outcry is that obesity requires pharmaceutical treatment because obesity is the harbinger of many other chronic conditions. This is incontrovertibly true. Well, except for the part suggesting that only pharmacotherapy can treat it. At precisely what point did a reasonable approach to eating, coupled with exercise, improved lifestyle, and psychological counseling fly out the window? Does Big Pharma have us all brainwashed to the extent that we automatically turn to their overpriced drugs? The more expensive, the better? A few months on some of them would pay for a personal trainer, a dietitian, and a counselor.

But one injection per week doesn’t involve much hardship. Even with the high price tag of GLP-1s, they’re an easy sell to a willing market. Finally, a solution that works! Oy vey.

Addicted to Crap?

No, obesity is not a disease, in the same sense that heroin or fentanyl addiction is not a disease. Both recreational drugs and recreational eating of ultra processed foods are scourges on our society, caused by greed and the resulting exploitation of human weakness. Moreover, drug pushers, of both the street-corner and the corporate varieties, encourage us. “I can’t help myself. They put crap in front of me, so I ate it!” The gratuitous weight-loss crowd indulges in the logical fallacy of justifying lack of self-control with externalized victimhood. They cry for institutionalized compensation and correction for the problems they themselves created.

If Less is More, Then More is Better

Now I am hearing rumbling about Eli Lilly testing Zepbound, their weight-loss approved tirzepatide product, at even higher doses than the current maximum of 15 mg. The tirzepitide-addicted weight-loss weenies have rapidly progressed to the current maximum dose, which one “influencer” dubbed “The King”. At present, they have nowhere to turn, at least with respect to on-label use. So, the proposed 20 and 25 mg doses will be like Christmas for those junkies whenever they come to the market. Then, they’ll max out at 25 mg until the next bump-up by Lilly. Will these be “The Emperor” and “The Galactic God”?

And Big Fooda will keep pushing crap to bring more and more fatties into the fold. Yep. We’re an addictive society — addicted to crappy food and addicted to what we perceive as miracle cures, at least until we and our complicit governmental regulators figure out that we’re screwing ourselves up even more.

Want to get a more scientific perspective on the scourge of ultra processed foods and the drugs that we need to fix their effects? Read “Metabolical”, by Dr. Robert Lustig.

My Progress

Doc Follow-Up

I visited Dr. DeLorean last Wedneday for a regular follow-up with a Covid twist. I had done preliminary blood work to check on my Mounjaro progress. As I had predicted based on my copious glucometer readings, the A1c was 5.8. DeLorean congratulated me and noted that I was only one-tenth of a point above his A1c. (He considers himself a paragon of health, a Yoga/running fanatic). I told him to take some Metformin, because he needed to get it down below 5.2.

We discussed Mounjaro dosage, deciding to leave it at 5 mg. The logic there is that we’re dealing with glucose control, not weight loss. I had noted that I hadn’t felt any appetite suppression since about my second week on 2.5 mg, back in June. However, as my doc affirmed, we embarked on this therapy to control glucose, it’s working, and weight loss was always a secondary objective. As DeLorean said, “I’m happy with your blood sugar, and I’ll take the weight loss if it comes.”

Oh well! “The King” will not grant us an audience anytime soon. (That’s how the “influencer” with the backwards baseball cap on YouTube characterized the 15 mg dose of Mounjaro).

No, I Don’t Want to Be on Mounjaro Forever

That is cool, because I don’t want to be on Mounjaro forever, regardless of Eli Lilly’s desire for that to happen. I want to wean myself off it and take charge of my own glucose. Given my history, this is a tough nut to crack, but I want to be taking as few drugs as possible if hard, motivated work can solve my problems. This decision could well be in the hands of my Part D PDP. For 2025, they have removed “Tier 6” from the plan completely, and Mounjaro was in Tier 6. I must wait for October 15, when they release the 2025 formulary, to discover whether they moved Mounjaro to another tier or will not cover it at all. This change probably relates to overprescription and overuse of the drug, coupled with the elimination of the Medicare Part D “Doughnut Hole”.

Glucose

As I mentioned, my lab tested A1c was 5.8, which equates to average blood glucose of 120 mg/dL over a three-month period. During the past week, my average was 114, using the readings from the Stelo.

Blood Pressure

This is a problem, and it might relate to either the aftermath of Covid-19 or my back issues. I have been seeing 140/80 consistently in the morning. I do not want to increase medication, as the issue must be secondary to some other pathology. Interestingly, before embarking on my vacation, I had reduced the medication and was averaging below 120/75. I screwed something up. Rather than throwing pills at it, I want to find the root cause.

Weight

My weight increased by 1.8 pounds during the week, but the baseline 206.6 pounds from a week ago represented precipitous drop during my Covid-19 infection. My appetite has now returned, so I would expect for weight to remain flat. The ten-pound weight loss during Covid was scary, so this is one time in my weight cycle that further weight loss is undesirable, at least for now.

Wrapping It Up

I hope my narcissistic rambling was useful to you in some way. Although Mounjaro is not right for everyone, as the direct-to-consumer advertising mantra goes, it has effectively controlled my glucose thus far. Sharing my experience might provide some ideas for those of you who have similar metabolic issues.

I mentioned two currently available non-prescription wearable glucose sensors. I was happy to see these products because my insurance does not cover the cost of the prescription version, and I could not justify the expense of self-pay. Many people were in the same boat. These sensors will play into an expanding market consisting of people concerned about their metabolic health.

My weight gain/weight loss story should trigger some of you with comparable stories, I hope in a constructive way. It is easy to fall into the trap of rationalization and blame-casting, while sweeping personal responsibility under the proverbial rug.

Finally, I always have an opinion. I present my side of the “obesity is a disease” postulates, which is contrary to much of the politically correct denial of personal responsibility extant today. I know that my position is extremely unpopular, as it puts people in charge of their own lives, a vanishing concept these days. However, the multi-trillion-dollar U. S. health care industry is broken. I cannot fix it, but I can tell you what I think is wrong with it.

Thanks for reading!

Share this:

  • Click to email a link to a friend (Opens in new window) Email
  • Post
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to print (Opens in new window) Print
  • More
  • Pocket
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...

Filed Under: Health, Mounjaro Tagged With: obesity

Mounjaro Update: Covid-19, CGMs, and Weekly Progress

Posted on September 16, 2024 Written by The Nittany Turkey 3 Comments

Mounjaro

Greetings, fellow Type Twos! I am back once again to describe my weekly progress on Mounjaro, and to provide some collateral information and observations for anyone interested in monitoring and improving their metabolic health. I should note that I do not offer medical advice, and I am not a doctor (thank God). Neither am I a paragon of metabolic health, offering leadership by example. Taking advice of any kind from me is a fool’s errand. Nevertheless, I might throw out an idea or two that might inspire you to do some research on your own. Opinions, I’ve got, already!

As you might have read in last week’s Post-Vacation Update, I returned from my “JOURNEY” (a real one, not the metaphorical kind the YouTube weenies take on their GLP-1 medication of choice) replete with cold symptoms, a fever, and a positive test for Covid-19. For a couple of days after testing positive on Wednesday, my symptoms worsened, but now I have settled into a flu-like state, in which I feel like I am in the Twilight Zone and lack energy. However, writing doesn’t require much energy. Also, it provides relaxation for me, so welcome to my weekly rant.

In this week’s column (if I might use that archaic newspaper-oriented terminology), I will describe the effect of Covid-19 on my weight. I will tell you about a new continuous glucose monitor (CGM) I am testing, one that has been approved for non-prescription use. Finally, I will wrap up with the week’s progress, albeit distorted by my unintended viral visitors.

Covid Weight Loss

I gave my doctor some advice. I told him that his cosmetic weight loss patients would love him if he treated them with Covid-19. The disease gives them the effortless avoirdupois reduction solution folks of that ilk crave. While this was obviously a facetious suggestion, I based it on my current experience since contracting the virus. In last week’s update, I had reported a two-pound weight loss while on vacation. I now believe that drop was due to Covid.

My weight had been holding steady until the last couple of days on the road. Now back at home, between September 11 and today, September 16, I have lost 9.2 pounds. If I count the other two pounds during the vacation, that is over eleven pounds lost over a week’s time. Again, I attribute the dramatic drop to Covid, not Mounjaro.

This is certainly not a sustainable formula for weight loss, and I strongly recommend against attending Covid parties with that aim in mind. Shedding pounds in this manner is stressful to the body. I try to stay hydrated, but I pee a lot, too. I must conscientiously avoid dehydration. Because my kidney function is impaired due to age and metabolic syndrome, dehydration is a dreadful thing, especially in conjunction with the Mounjaro and other medicines I am taking.

If I experience an uncomplicated recovery from Covid, my hope is that I regain some of my ill-gotten losses. How’s that for a twist?

Throw in Sciatica, too!

When it rains, it pours. During our vacation, I tweaked my lower back, which has long been a ticking time bomb. A CT scan a couple of years ago characterized “moderate to severe multilevel degenerative disc disease within the lumbar spine predominantly involving the mid and lower lumbar spine”. In conjunction with taking Mounjaro, I had ramped up my exercise program, which seemed to result in less back pain. However, on vacation, awkwardly tossing around a fifty-pound suitcase, I messed something up.

So, now I need to deal with the back, too. The lower back pain radiates to the right-side butt and down the right leg. I cannot stand in one place for long. I eschewed an ER visit on the trip so I could get home quicker. Of course, that meant dealing with pain while driving for three days. Undoubtedly, the seated position while driving did not help the situation.

My self-treatment options are limited to Extra-Strength Tylenol, which doesn’t work. I need to get the damn thing evaluated and seek some treatment for it, because it is destroying my sleep. My hope is that I can avoid opiates and surgery, as I would prefer corticosteroids, muscle relaxers, and physical therapy. A visit to a local ER might be needed to get the ball rolling. I was tempted to go there last night while tossing and turning and not achieving any relief from the pain. We’ll see…

Stelo Glucose Biosensor

I discovered that the FDA had approved a new product from Dexcom, a wearable device like a continuous glucose monitor that does not require a prescription, is self-paid, and is available to anyone. Previously, I had eschewed CGMs, such as the Dexcom G7, because our Medicare regulators would not cover their cost for a Type 2 diabetic unless 1) on insulin, or 2) had documented hypoglycemic episodes. Even if my doctor were to prescribe a CGM, the out-of-pocket cost would have been over $300/month. Everybody has his price, and for that kind of money, I’ll endure finger pricks a few times per day. However, this new product offered by Dexcom for less than $100 per month piqued my interest.

Dexcom, makers of the flagship G7 CGM, saw the need for people in my category who want to track their glucose variations, so they developed this dumbed-down product, called Stelo. It is available directly from the company for under $100 for a month’s supply, or $90 for a monthly subscription. Each monitor is good for fifteen days, during which it communicates with the Stelo app on my phone with a graphical update every fifteen minutes. The Stelo cannot be integrated with an insulin pump, so the granularity of its measurements is coarser than that of the G7. It is just intended as an informational device. Dexcom labels Stelo as a “glucose biosensor”, not as a continuous glucose monitor.

Get It Quickly!

Interestingly, although I ordered Stelo directly from Dexcom through their website, the product was delivered the next day by Amazon. Amazon now makes deals with third-party companies wishing to avail themselves of Amazon’s rapid and diffuse distribution network. I suppose this form of distribution applies in selected areas where Amazon has a strong presence. That’s everywhere, right?

The Stelo cannot export information (yet) to share with a doctor or with readers of my column. In fact, I wanted to send an SMS to my wife with a screenshot of the glucose graph, but I could not do a screenshot. The message was that screenshots were prohibited due to security restrictions. WTF? I hereby request that Dexcom at least give us the capability to download information so we can analyze it in Excel if nothing else. Furthermore, show-and-tell with the doctor would be a good thing. I am assuming that the FDA approval might have been contingent on restricting the use of data to personal amusement, but I sure hope there’s a way around this restriction.

[UPDATE: There IS a way around it, in the form of the “Clarity” app from Dexcom. I’ll tell you more in next week’s update.]

(This is an entertainment device, not to be confused with a serious medical device, and you may not base your medical decisions on its readings under penalty of being acknowledged as being as stupid as the FDA and Dexcom’s lawyers want you to be). Oy vey!

Playing with My Biosensor

I have been wearing the Stelo “biosensor” for two days and have experimented with glucose-spiking ingestion, like eating several types of meals, as well as taking one Mounjaro injection. It is interesting to observe the glucose rapidly increasing, then falling off slowly after a carb-laden meal, a graphical depiction of insulin resistance. The readings are biased about 10-12 points higher than my Contour Next glucometer, which has tracked very closely with lab blood testing in the past. But the real benefit I will derive is in viewing the ups and downs. Absolute numbers are not as important, so long as they stay in range. And I will continue to use my glucometer at least once per day.

I cannot yet say whether I will be sticking with the Stelo once the novelty wears off. I signed up for the $90/month subscription, which is cancelable anytime. We’ll see whether Dexcom keeps that promise when the time comes. In the meantime, I will provide further observations and conclusions as time goes on and I find undiscovered features or deficits.

Asking whether I am wearing a glucose monitor or a glucose biosensor is like asking whether that thing in the sky is a hawk or a bird.

Weekly Mounjaro Results Recap

Undaunted by Covid, I will now present the skewed results for the week in the usual manner. As I mentioned, shockingly, my weight loss since last Wednesday is 9.2 pounds. Glucose average for the period was 104. However, my blood pressure has been running high, about 140/80. I attribute that to the illness and the back pain I have been experiencing for the past ten days.

I’ll be back next week, hoping to be in a better frame of physical and mental health.

Share this:

  • Click to email a link to a friend (Opens in new window) Email
  • Post
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to print (Opens in new window) Print
  • More
  • Pocket
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...

Filed Under: Health, Mounjaro

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 29
  • Next Page »

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 70 other subscribers

Recent Comments

  • Elizabeth Ellen Harris on Week 54 Mounjaro Update: A Turkey’s Medical Marathon
  • The Nittany Turkey on Week 54 Mounjaro Update: A Turkey’s Medical Marathon
  • Lizard on Week 54 Mounjaro Update: A Turkey’s Medical Marathon
  • Week 54 Mounjaro Update: A Turkey's Medical Marathon - The Nittany Turkey on Week 53 Mounjaro Update: Jacked Lab Monkeys & Med Purgatory
  • Week 53 Mounjaro Update: Jacked Lab Monkeys & Med Purgatory - The Nittany Turkey on Week 51 Mounjaro Update: Wake Up and Smell the Coffee!

Latest Posts

  • Mounjaro Update Week 56: Big Pharma Wins, You Lose (Weight) June 30, 2025
  • Week 55 Mounjaro Update: We’re the Drug Cops and We’re Here to Help! June 23, 2025
  • Week 54 Mounjaro Update: A Turkey’s Medical Marathon June 16, 2025
  • Week 53 Mounjaro Update: Jacked Lab Monkeys & Med Purgatory June 9, 2025
  • Week 52 Mounjaro Update: Steroid Shot Sparks Spooky Sugar Spike June 2, 2025

Penn State Blogroll

  • Black Shoe Diaries
  • Onward State
  • The Lion's Den
  • Victory Bell Rings

Friends' Blogs

  • The Eye Life

Penn State Football Links

  • Bleacher Report: Penn State Football
  • Blue White Illustrated
  • Lions247
  • Nittany Anthology
  • Penn State Sports
  • PennLive.com
  • The Digital Collegian

Whodat Turkey?

The Nittany Turkey is a retired techno-geek who thinks he knows something about Penn State football and everything else in the world. If there's a topic, we have an opinion on it, and you know what "they" say about opinions! Most of what is posted here involves a heavy dose of hip-shooting conjecture, but unlike some other blogs, we don't represent it as fact. Read More…

  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • RSS
  • Twitter

Subscribe via Email

Enter your email address to subscribe to the Nittany Turkey and receive notifications of new posts by email.

Join 70 other subscribers
July 2025
S M T W T F S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    

Archives

Categories

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2025 · Focus Pro Theme on Genesis Framework · WordPress · Log in

 

Loading Comments...
 

    %d